MILBEMYCINE OXIME PRAZIQUANTEL ALFAMED II 4 MG/10 MG COMPRIMES PELLICULES POUR PETITS CHATS ET CHATONS
MILBEMYCINE OXIME PRAZIQUANTEL ALFAMED II 4 MG/10 MG COMPRIMES PELLICULES POUR PETITS CHATS ET CHATONS
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
MILBEMYCINE OXIME PRAZIQUANTEL ALFAMED II 4 MG/10 MG COMPRIMES PELLICULES POUR PETITS CHATS ET CHATONS
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime4.00/milligram(s)1.00Tablet
-
Praziquantel10.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application - change in active substance(s) (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfamed
- Virbac
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/7860227 8/2024
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 23/04/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 23/04/2025
fr-puar-700000165540-np-rpe973-fr.pdf
French (PDF)
Download Published on: 7/01/2026